Similar articles

• Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.

  Bartonícek V. Bartonícek V. Med Pharmacol Exp Int J Exp Med. 1967;16(2):142-6. Med Pharmacol Exp Int J Exp Med. 1967. PMID: 5298397 No abstract available.
• Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.

  Christmas AJ, Hall DW, Hayward A, Maxwell DR. Christmas AJ, et al. Br J Pharmacol. 1970 May;39(1):207P-208P. Br J Pharmacol. 1970. PMID: 5420104 Free PMC article. No abstract available.
• P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.

  Sanders-Bush E, Sulser F. Sanders-Bush E, et al. J Pharmacol Exp Ther. 1970 Nov;175(2):419-26. J Pharmacol Exp Ther. 1970. PMID: 5312363 No abstract available.
• [Monoamines and manic-depressive syndromes].

  Tissot R. Tissot R. Schweiz Arch Neurol Neurochir Psychiatr. 1967;100(2):487-98. Schweiz Arch Neurol Neurochir Psychiatr. 1967. PMID: 4873952 Review. French. No abstract available.
• [New data on monoamine oxidase inhibitors].

  Gorkin VZ. Gorkin VZ. Vestn Akad Med Nauk SSSR. 1971;26(11):23-8. Vestn Akad Med Nauk SSSR. 1971. PMID: 4942003 Review. Russian. No abstract available.